CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer

British Journal of Cancer

Volumn 89, Issue 3, 2003, Pages 533-538

  Coventry, B J ^a   Morton, J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Breast cancer; CD1a; Dendritic cells; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; T6 ANTIGEN; TAMOXIFEN; CD1 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELL DENSITY; CELL INFILTRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PROGNOSIS; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; VALIDATION PROCESS; BREAST TUMOR; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; BREAST NEOPLASMS; DENDRITIC CELLS; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0041976915     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601114     Document Type: Article

References (63)

1. Ambe K, Mori M, Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to clinical progress. Cancer 63: 496-503
2. Australian Bureau of Statistics (2002) Causes of Death Australia. Canberra: ABS (www.abs.gov.au)
3. Austyn JA (1993) The dendritic cell system and anti-tumour immunity. In vivo 7: 193-202
4. Basset F, Soler P, Whyllie L (1974) Langerhans cells in bronchoalveolar tumour of the lung. Vich Arch (Pathol Anat) 362: 315-330
5. Baxevanis CN, Dedoussis GVZ, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M (1994) Tumour specific cytolysis by tumour infiltrating lymphocytes in breast cancer. Cancer 74 (4): 1275-1283
6. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190 (10): 1417-1426
7. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B (1996) Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28 (4): 321-327
8. Bigotti G, Coli A, Castagnola D (1991) Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histological grade. Prostate 19: 73-87
9. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377
10. Coventry BJ (1999) Review of CD1a putative dendritic cells in human breast cancers. Anti Cancer Res 19: 3183-3188
11. Coventry BJ, Austyn JM, Chryssidis S, Hankins D, Harris A (1997) Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer. In Dendritic cells in Fundamental and Clinical Immunology, Ricciardi-Castagnoli P (ed) Vol 3. NY: Plenum Press, Adv Exptl Med Biol 417: 571-577
12. Coventry BJ, Bradley J, Skinner JM (1995) Differences between standard and high-sensitivity immunoperoxidase staining methods in tissue sections-comparison of immunoperoxidase staining methods using computerised video image analysis. Pathology 27: 221-224
13. Coventry BJ, Lee PL, Gibbs D, Hart DN (2002) Dendritic cell density and activation status in human breast cancer-CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 86: 546-551
14. Coventry BJ, Neoh S, Mantzioris B, Skinner JM, Bradley J, Zola H (1994) Comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface. J Histochem Cytochem 42: 1143-1149
15. Coventry BJ, Weeks S, Heckford S, Sykes P, Skinner J, Bradley J (1996) Lack of interleukin-2 (IL-2) cytokine expression despite IL-2mRNA transcription in tumour infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers. J Immunol 156: 3486-3492
16. Dallal RM, Christakos P, Lee K, Egawa S, Son YI, Lotze MT (2002) Paucity of dendritic cells in pancreatic cancer. Surgery 131 (2): 135-138
17. Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast cancer: a reproducibility study. Cancer 73: 2765-2770
18. David R, Buchner A (1980) Langerhans cells in pleomorphic adenoma of sub-mandibular salivary gland. J Pathol 131: 127-135
19. Dunnill MS (1968) Quantitative methods in histology. In Recent Advances in Clinical Pathology, Dyke SC (ed.) London: Churchill Livingstone
20. Eisenthal A, Polyvkin N, Bramante-Schreiber L, Misonznik F, Hassner A, Lifschitz-Mercer B (2001) Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol 32 (8): 803-807
21. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. HistopathoIogy 19: 403-410
22. Fox SB, Jones M, Dunnill MS, Gatter KC, Mason DY (1989) Langerhans cells in human lung tumour: an immunohistochemical study. Histopathology 14: 269-275
23. Furukawa T, Watanabe S, Kodama T, Sato Y, Sihimosato Y, Suemasa K (1985) T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 56: 2651-2656
24. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3 (3): 483-490
25. Galea MH, Blarney RW, Elston CW, Ellis IO (1992) The Nottingham Progno-stic Index in primary breast cancer. Breast Cancer Res Treat 22: 207-219
26. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, Fini-Storchi O (1991a) Correlation between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 101: 487-493
27. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C, Bondi R (1991b) Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117 (9): 1007-1010
28. Gatter KC, Morris HB, Roach B (1980) Langerhans cells and T cells in human skin tumours. Immunohistochemical study. Histopathology 8: 229-244
29. Goldman SA, Baker E, Weyant RJ, Clark MR, Myers JN, Lotze MT (1998) Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124: 641-646
30. Hammar S, Bockus D, Remington F (1986) The widespread distribution of Langerhans cells in pathological tissue. An ultrastructural and immunohistochemical study. Human Pathol 17: 894-905
31. Heizmann CW, Fritz G, Schafer BW (2002) S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-68
32. Hillenbrand EE, Neville AM, Coventry BJ (1999) Immunohistochemical localisation of CD1a-positive putative dendritic cells in human breast tumours. Br J Cancer 79: 940-944
33. Inoue K, Furihata M, Ohtsuki Y, Fujita Y (1993) Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virch Arch A Pathol Anat Histopathol 422 (5): 351-355
34. Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N (2003) Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104 (1): 92-97
35. Kikuchi K, Kusama K, Taguchi K, Ishikawa F, Okamoto M, Shimada J, Sakashita H, Yamamo Y (2002) Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 22 (2A): 545-557
36. Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D (1999) Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 84 (3): 309-314
37. Makin CA, Bobrow LG, Bodmer WF (1984) Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol 37 (9): 975-983
38. Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H, Sugimachi K (1990) Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer 65 (10): 2261-2265
39. Nixon AJ, Schnitt SJ, Gelman R, Gage I, Bornstein B, Hetelekidis S, Recht A, Silver B, Harris JR, Connolly JL (1996) Relationship of tumour grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 78: 1426-1431
40. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T (1986) Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57: 100-105
41. Page DL, Jensen RA, Simpson JF (1998) Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51: 195-208
42. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JFR, Ellis IO (1995) Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of the two histological prognostic features in operable breast carcinoma. Histopathotogy 27: 219-226
43. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Alston CW, Robertson JF, Nicholson R, Balmey RW, Ellis IO (1995) Assessment of the new proliferation marker MIB 1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71: 146-149
44. Scarff RW, Tolono H (1968) Histological Typing of Breast Tumours (International Histological Classification of Tumours: No 2). Geneva: World Health Organization
45. Schenk P (1980) Langerhans cells in invasive laryngeal carcinoma. Laryngol Rhinol Otol (Stuttg) 59: 232-237
46. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W (1988) Dendritic/Langerhans cells in and prognosis in patients with papillary thyroid carcinoma: immunohistochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89: 295-300
47. Schwartzentruber DJ, Solomon D, Rosenberg SA, Topalian SL (1992) Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother 12 (1): 1-12
48. Shaw S (1998) CD Guide. Sixth International Leukocyte Typing Workshop, Kobe, Japan. In Leukocyte Typing VI. Kishimoto T, Kikutani H, von dem Borne AEG, Goyert SM, Mason D, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H (eds). pp 1109-1110. New York: Garland press Ltd
49. Sieling PA (1998) A broader role for CD1 in the spectrum of immune responses. Immunologist 6 (3): 112-116
50. Troy A, Davidson P, Atkinson C, Hart D (1998b) Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol 160 (1): 214-219
51. Troy AJ, Davidson PJ, Atkinson CH, Hart DN (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 161 (6): 1962-1967
52. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998a) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4 (3): 585-593
53. Tsuge T, Yamakawa M, Tsukamoto M (2000) Infiltrating dendritic/ Langerhans cells in primary breast cancer. Breast Cancer Res Treat 59 (2): 141-152
54. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K, Sugimachi K (1987) Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 59: 501-505
55. Veronesi S, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, Salvadori B (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19-27
56. Vitolo D, Kanbour A, Johnson JT, Herberman RB, Whiteside TL (1993) In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment. Eur J Cancer 29A (3): 371-377
57. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51 (4): 573-580
58. Whiteside TL, Miescher S, Hurlimann J, Moretta L, von Fliedner V (1986a) Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Cancer Immunol Immunother 23 (3): 169-178
59. Whiteside TL, Miescher S, MacDonald HR, Von Fliedner V (1986b) Separation of tumor-infiltrating lymphocytes from tumor cells in human solidtumors. A comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods 90 (2): 221-233
60. Willgeroth C, Floegel R, Rosier B (1992) The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer. Zentralbl Chir 117 (11): 603-606
61. Younes MS, Robertson EM, Bensome SA (1968) Electron microscope observation on Langerhans cells in the cervix. Am J Obstet Gynecol 102 (3): 397-403
62. Zeid NA, Muller HK (1993) S-100 positive dendritic cells in human lung tumours associated with cell differentiation and enhanced survival. Pathology 25: 338-343
63. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. (1997) Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277 (5324): 339-345